Immunohistochemistry (IHC) Market Expected to Cross CAGR of 7.5% And expected to increase to US$ 3,348.7 Million by 2028 | Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd

Market Overview:

Immunohistochemistry (IHC) uses antibodies that recognize specific antigens in tissue sections. These antibodies are highly specific and bind only the antigen of interest in each tissue section. Different detection systems are used to visualize the antibody-antigen interaction. The results of immunohistochemistry can be used to identify abnormal cells and diseases. With the help of this procedure, physicians can predict the effectiveness of treatment for patients suffering from various conditions. Further, this technique can be done at home by non-experts, who can perform this type of test for themselves. Apart from its clinical applications, immunohistochemistry is a powerful research tool, which offers excellent information on the protein expression in tissue structures and isolated cells. With these techniques, researchers can also identify cellular events such as cell death and tumor growth.

Competitive Landscape:

Major players operating in the global immunohistochemistry (IHC) market include Genemed Biotechnologies, Inc., Rockland Immunochemicals, Inc., BioVision Inc, Diagnostic Biosystems, Inc., Biogenex Laboratories, Elabscience, Inc., Biocare Medical, LLC, Eagle Biosciences, Inc., Sakura Finetek Japan Co., Ltd., CANDOR Bioscience GmbH, Miltenyi Biotec, Bio SB, Inc., Cell Signaling Technology, Inc., PHC Holdings Corporation, Thermo Fisher Scientific, Inc., Takara Bio, Inc., PerkinElmer, Inc., Dickinson and Company, Becton, Abcam plc, Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Danaher Corporation, and F. Hoffman-La Roche AG.

LIMITED TIME OFFER – Hurry Up!!!

Buy Now To Avail Flat 30% Off

Buy This Complete Business Report with Discounted Price @ https://www.coherentmarketinsights.com/insight/buy-now/4795

Key Market Drivers:

Increasing approval of new pipeline products in the world by authorities is the major factor that is expected to drive the growth of the global immunohistochemistry (IHC) market. For instance, in August 2021, the U.S. Food and Drug Administration gave approval for Roche’s companion diagnostic test called VENTANA MMR RxDx, which is based on immunohistochemistry for solid tumors. The basic steps of immunohistochemistry (IHC) are setting up the assay, incubating the specimen for a specific amount of time (usually one hour), obtaining fluorescent labels, and staining the samples using appropriate antigens. The primary antibody binds to a certain epitope on the target protein. The secondary antibody is then coupled to a molecule that acts as a reporter, and a chemical substrate is used to detect the binding of the primary antibody to the antigen. The result is a colored precipitate, which can be used to determine if the epitope is present in a particular tissue section. Increasing usage of immunohistochemistry in medical diagnostics is estimated to propel the growth of the global immunohistochemistry (IHC) market.

Covid-19 Impact Analysis:

The COVID-19 pandemic had put a tremendous amount of impact on the sectors responsible for developing new vaccines and treatments, in order to cure the COVID-19 infection. However, all these boosted the growth of the global immunohistochemistry (IHC) market, with key market players launching advanced products and services in the market.

Key Takeaways:

• The size of the global immunohistochemistry (IHC) market is assessed to increase at a CAGR of 7.7%, owing to increasing product and service launches by key market players. For instance, in August 2021, Agilent got a CE-IVD mark in the European market for the company’s PD-L1 IHC 22C3 pharmDx assay, in order to identify patients suffering from oesophageal cancer with KEYTRUDA.
• North America is expected to dominate the growth of the global immunohistochemistry (IHC) market, owing to the prevalence of diagnostic labs in the region. For instance, according to American Clinical Laboratory Association, there are currently 29,151 diagnostic and medical laboratories in the U.S.
• The Asia Pacific is estimated to witness high growth in the global immunohistochemistry (IHC) market, owing to the increasing advancements in the healthcare sector in the region. Moreover, increasing investment in the medical sector is assessed to enhance the growth of the market.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4795

Reasons to Purchase This Report

• Current and future of Immunohistochemistry (IHC) Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4795

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Product
     • Market Snapshot, By Application
     • Market Snapshot, By End User
     • Market Snapshot, By Region
     • Market Opportunity Map
3. Global Immunohistochemistry (IHC) Market Insights
   • Drivers
   • Restraints
   • Opportunity
   • Impact Analysis
   • Key Developments
   • Merger, Acquisition & Agreements
   • Pipeline Analysis
   • Regulatory Scenario
   • Reimbursement Scenario
   • Market Trends
   • Recent Product Launch/Approvals
   • PEST Analysis
4. Global Immunohistochemistry (IHC) Market – Impact of Coronavirus (Covid-19) Pandemic
   • Economic Impact
   • Epidemiology
   • Impact on Supply and Demand
5. Global Immunohistochemistry (IHC) Market, By Product, 2017 – 2028 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Antibodies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Primary Antibodies
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Secondary Antibodies
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
   • Equipment
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Slide Staining Systems
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Tissue Microarrays
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Tissue Processing Systems
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Slide Scanners
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Others
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
   • Reagents
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Histological Stains
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Blocking Sera and Reagents
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Chromogenic Substrates
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Fixation Reagents
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Stabilizers
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Others
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
   • Kits
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
6. Global Immunohistochemistry (IHC) Market, By Application, 2017 – 2028 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Diagnostics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Cancer
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Infectious Diseases
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Cardiovascular Diseases
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Autoimmune Diseases
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Diabetes Mellitus
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
       • Others
         • Introduction
         • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
   • Drug Testing
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
   • Forensic Applications
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028 (US$ Million)
7. Global Immunohistochemistry (IHC) Market, By End User, 2017 – 2028 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Hospitals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Diagnostic Laboratories
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Research Institutes
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
8. Global Immunohistochemistry (IHC) Market, By Region, 2017 – 2028 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2028, (US$ Million)
       • U.S.
       • Canada
   • Latin America
     • Brazil
     • Mexico
     • Argentina
     • Rest of Latin America
   • Europe
     • Germany
     • U.K.
     • France
     • Italy
     • Spain
     • Russia
     • Rest of Europe
   • Asia Pacific
     • China
     • India
     • Japan
     • Australia
     • South Korea
     • ASEAN
     • Rest of Asia Pacific
   • Middle East
     • GCC
     • Israel
     • Rest of Middle East
   • Africa
     • South Africa
     • Central Africa
     • North Africa

View Press Release: https://www.coherentmarketinsights.com/press-release/immunohistochemistry-market-4055

About Us: